thymidine has been researched along with isoquinoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agama, KK; Antony, S; Cushman, M; Holbeck, SL; Hollingshead, M; Miao, ZH; Morrell, A; Nagarajan, M; Pommier, Y; Varticovski, L; Wright, MH | 1 |
1 other study(ies) available for thymidine and isoquinoline
Article | Year |
---|---|
Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity.
Topics: Animals; Antineoplastic Agents; Catalysis; Cell Death; DNA; DNA Damage; DNA Topoisomerases, Type II; G1 Phase; Humans; Indenes; Intercalating Agents; Isoquinolines; Melanoma; Mice; Mice, Nude; Nucleic Acid Conformation; Thymidine; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2006 |